FDA Inspection 1223241 — Rising Pharma Holding, Inc.
The FDA completed an inspection of Rising Pharma Holding, Inc. on Nov 3, 2023 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- East Brunswick, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)